Literature DB >> 9747148

Localisation of protein Z in vascular lesions of patients with atherosclerosis.

J Greten1, I Kreis, B Liliensiek, J Allenberg, J Amiral, R Ziegler, P P Nawroth.   

Abstract

BACKGROUND: The deposition of protein Z was investigated in atherosclerotic vascular lesions of patients with diabetes mellitus or atherosclerotic vascular disease without diabetes in comparison to controls. PATIENTS AND METHODS: Protein Z antigen was evidenced by immunohistochemistry in arteries of 5 healthy control patients, 11 diabetic patients with arterio-occlusive disease and 7 patients suffering from arterio-occlusive disease without diabetes. For immunohistochemistry, a commercially available antibody was taken as first antibody, and immunopositivity was evaluated independently by two investigators (J.G.; I.K.) as negative (0), positive (+) and strongly positive (++). The results were assessed by the Whitney-Mann-Wilcoxon test.
RESULTS: Macrovascular endothelial cells were stained positive for protein Z in all arteries studied. Arteries of controls did not show significant immunopositivity in cells other than macrovascular endothelial cells, while the microvascular endothelial cells of control arteries were largely negative. The proliferating subendothelial space in atherosclerotic vascular lesions showed significant immunopositivity for protein Z. In contrast to control arteries, the microvascular endothelial cells of the proliferating areas stained positive. The staining pattern of the subendothelial space was similar in atherosclerotic vessels independent of the risk factor for atherosclerosis. Plaques were immunopositive for protein Z, too.
CONCLUSIONS: Protein Z is present in atherosclerotic vascular lesions of diabetic and non-diabetic patients, but not in the subendothelial space and microvascular endothelial cells of healthy controls. Since protein Z-positivity was detected in microvascular endothelium as well as in extra-vascular deposits around plaques, it may play a role in the development of these lesions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9747148

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  9 in total

Review 1.  A meta-analysis of potential risks of low levels of protein Z for diseases related to vascular thrombosis.

Authors:  Francesco Sofi; Francesca Cesari; Rosanna Abbate; Gian Franco Gensini; George Broze; Sandra Fedi
Journal:  Thromb Haemost       Date:  2010-01-13       Impact factor: 5.249

2.  Protein Z is present in human breast cancer tissue.

Authors:  Ewa Sierko; Marek Z Wojtukiewicz; Lech Zimnoch; Piotr Tokajuk; Walter Kisiel
Journal:  Int J Hematol       Date:  2011-04-12       Impact factor: 2.490

3.  Low protein Z plasma level is a risk factor for acute myocardial infarction in coronary atherosclerosis disease patients.

Authors:  Baoxin Liu; Yong Li; Jiachen Luo; Liming Dai; Jinlong Zhao; Hongqiang Li; Qiqiang Jie; Dongzhi Wang; Xin Huang; Yidong Wei
Journal:  Thromb Res       Date:  2016-10-13       Impact factor: 3.944

4.  Protein Z-deficiency is associated with enhanced neointima formation and inflammatory response after vascular injury in mice.

Authors:  Antje Butschkau; Nana-Maria Wagner; Laura Bierhansl; Berit Genz; Brigitte Vollmar
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

5.  Low plasma protein Z levels in patients with ischemic colitis.

Authors:  Ioannis E Koutroubakis; Angeliki Theodoropoulou; Aekaterini Sfiridaki; Elias A Kouroumalis
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

6.  Protein Z-dependent protease inhibitor and protein Z in peripheral arterial disease patients.

Authors:  F Sofi; F Cesari; Y Tu; G Pratesi; R Pulli; C Pratesi; G F Gensini; R Abbate; S Fedi; G J Broze
Journal:  J Thromb Haemost       Date:  2009-02-18       Impact factor: 5.824

7.  Role of protein z in stroke.

Authors:  Huyen A Tran; John W Eikelboom
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-06

8.  Protein Z/protein Z-dependent protease inhibitor system in loco in human gastric cancer.

Authors:  Ewa Sierko; Marek Z Wojtukiewicz; Lech Zimnoch; Piotr Tokajuk; Krystyna Ostrowska-Cichocka; Walter Kisiel
Journal:  Ann Hematol       Date:  2013-10-26       Impact factor: 3.673

9.  Quantification of protein Z expression in lung adenocarcinoma tissues and cells.

Authors:  Hong Wang; Fang Huang; Xue-Yi Pan; Ze-Bin Guan; Wen-Bing Zeng; Ming-Jie Li; Rui-Hao Zhang
Journal:  Springerplus       Date:  2016-07-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.